Opportunities and Challenges for AI in Drug Discovery

Within the pharmaceutical industry, there has been considerable focus on AI for drug discovery and development. This industry is commonly referred to as “AI for Drug Discovery” and includes research organizations, AI innovators – both early-stage and well-funded biotech companies, and multinational pharma companies. Though AI has recently taken hold in the marketplace, computational approaches to drug discovery – namely in chemistry and biology – have a history that dates back almost as far as electronic computing itself.